Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway.
Saved in:
| Title: | Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway. |
|---|---|
| Authors: | Kato M; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Takahashi F; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Sato T; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Mitsuishi Y; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Tajima K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Ihara H; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Nurwidya F; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Baskoro H; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Murakami A; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kobayashi I; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Hidayat M; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Shimada N; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Sasaki S; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan., Mineki R; Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan., Fujimura T; Laboratory of Bioanalytical Chemistry, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan., Kumasaka T; Department of Pathology, Japanese Red Cross Medical Center, Tokyo, Japan., Niwa SI; Link Genomics, Incorporated, Tokyo, Japan., Takahashi K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2020 Oct 29; Vol. 14, pp. 4593-4603. Date of Electronic Publication: 2020 Oct 29 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
